Distribution (percentiles) of study characteristics, tendinopathy locations and outcome domains calculated across treatment arms
| Study characteristic | 0% | 10% | 20% | 30% | 40% | 50% | 60% | 70% | 80% | 90% | 100% |
| Participants per group | 5 | 10 | 13 | 16 | 19 | 20 | 24 | 28 | 31 | 44 | 70 |
| Mean age | 22.5 | 29.5 | 39.8 | 42.6 | 44.0 | 46.0 | 47.9 | 48.7 | 49.9 | 51.9 | 62.1 |
| Mean symptom duration (months) | 0.85 | 4.4 | 6.0 | 7.8 | 11.6 | 17.5 | 19.5 | 24.1 | 29.7 | 37.4 | 98.5 |
| Publication year | 1998 | 2005 | 2007 | 2009 | 2012 | 2014 | 2015 | 2017 | 2017 | 2019 | 2020 |
| Intervention length (weeks) | 2 | 4 | 4 | 4 | 6 | 8 | 12 | 12 | 12 | 12 | 21 |
| Measurement duration (weeks) | 0.7 | 3 | 4 | 4 | 5 | 6 | 6 | 9 | 12 | 13 | 104 |
| Tendinopathy location | No of TA (%) | No of effects (%) | Outcome domain | No of TA (%) | No of effects (%) | ||||||
| Rotator cuff | 77 (45.0) | 817 (56.2) | Disability | 142 (83.0) | 447 (30.7) | ||||||
| Achilles | 45 (26.3) | 321 (22.1) | Pain | 122 (71.3) | 406 (27.9) | ||||||
| Lateral elbow | 29 (17.0) | 227 (15.6) | |||||||||
| Patellar | 20 (11.7) | 89 (6.1) | PFC | 59 (34.5) | 320 (22.0) | ||||||
| Dominant therapy class | No of TA (%) | No of effects (%) | ROM | 30 (17.5) | 159 (10.9) | ||||||
| Resistance | 124 (72.5) | 1014 (69.7) | Function | 29 (17.0) | 68 (4.7) | ||||||
| Flexibility | 25 (14.6) | 215 (14.8) | |||||||||
| Proprioception | 21 (12.3) | 223 (15.3) | QoL | 12 (7.0) | 54 (3.7) | ||||||
| Vibration | 1 (0.6) | 2 (0.1) | |||||||||
Pain, pain without further specification; Pain time, pain over a specified time; PFC, physical function capacity; QoL, quality of life; ROM, range of motion; TA, treatment arms .